A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Healthy

Interventions

DRUG

Magicbuvir

1 tablet contains 400 mg sofosbuvir

DRUG

Sovaldi (fist dose)

1 tablet contains 400 mg sofosbuvir

DRUG

Sovaldi (second dose)

1 tablet contains 400 mg sofosbuvir

Trial Locations (1)

Genuine Research Center GRC, Cairo